EMJ Microbiology and Infectious Diseases 4 [Supplement 4] 2023

This comprehensive review article explores key points presented by experts during an integrated symposium held on 17^thApril 2023 in Copenhagen, Denmark, as part of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

Respiratory Diseases in Adults

According to the WHO, the proportion of the world’s population aged over 60 years will almost double, from 12% to 22%, between 2015–2050… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Assessing CBNAAT for Extrapulmonary Tuberculosis Diagnosis: A Retrospective Study

Tuberculosis (TB) represents a significant global public health issue, ranking as the 13th leading cause of mortality and standing as the… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Adverse Drug Events from First-Line Anti-tuberculosis Drugs

Tuberculosis (TB) is caused by the bacteria Mycobacterium tuberculosis, a complex, rod-shaped, non-spore-forming, thin, aerobic bacterium… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Challenges of Unpredictability: Meningitis Prevention

In this informative interview article, expert Federico Martinón-Torres discusses the unpredictability of meningitis and the challenges in preventing, diagnosing, and treating this rare infectious disease. Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

EMJ Microbiology and Infectious Diseases 4 [Supplement 4] . 2023

In this issue

Respiratory Diseases in Adults

Assessing CBNAAT for Extrapulmonary Tuberculosis Diagnosis: A Retrospective Study

Adverse Drug Events from First-Line Anti-tuberculosis Drugs

Challenges of Unpredictability: Meningitis Prevention

Therapy Area

About Us

EMJ Microbiology and Infectious Diseases 4 [Supplement 4] . 2023

In this issue

Latest articles

Respiratory Diseases in Adults

Assessing CBNAAT for Extrapulmonary Tuberculosis Diagnosis: A Retrospective Study

Adverse Drug Events from First-Line Anti-tuberculosis Drugs

Challenges of Unpredictability: Meningitis Prevention